tradingkey.logo
tradingkey.logo
Search

Verona jumps after Merck's $10 billion acquisition

ReutersJul 9, 2025 11:00 AM
facebooktwitterlinkedin
View all comments0

U.S.-listed shares of lung therapy firm Verona Pharma VRNA.O I9SAy.F jump 20.3% to $104.47 premarket

Merck MRK.N will buy London-based Verona Pharma for about $10 billion

Merck will pay $107 per American depository share for Verona

The purchase price is a premium of about 23% to Verona ADS' last closing price

*The Financial Times first reported the deal on Wednesday

Up to last close, stock up 87% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI